Lei Wang is an author at Sanofi (United States).
Publications per year
2024–2024
1
1
PROTAC-mediated NR4A1 degradation as a novel strategy for cancer immunotherapy
Lei Wang, Yufeng Xiao, Yuewan Luo et al. · The Journal of Experimental Medicine · 2024 · 19 citations · Full text
Rows per page
1–1 of 1